Access cutting-edge chronic migraine treatment through this clinical trial at a research site in Jacksonville. Study-provided care at no cost to qualified participants.
Access chronic migraine specialists in Jacksonville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic migraine treatment provided free
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Sponsor: Eli Lilly and Company
Check if you qualify for this chronic migraine clinical trial in Jacksonville, FL
If you're searching for chronic migraine treatment options in Jacksonville, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Jacksonville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.